Targeting a Key Driver of Cancer
The Ras protein is one of the most common and deadly drivers of cancer, yet it has eluded any drug therapies for decades. Scientists are getting close to changing that.
University of California San Francisco
Give to UCSF
Families With an Autistic Child Are a Third Less Likely to Have More Kids
Parents who have a child with autism spectrum disorder (ASD) are about one third less likely to have more children than families without an affected child, according to a study led by a UC San Francisco researcher.
Mexican Genetics Study Reveals Huge Variation in Ancestry
In the most comprehensive study of the Mexican population to date, researchers from UCSF and Stanford University, along with Mexico’s National Institute of Genomic Medicine, have identified tremendous genetic diversity.
Longer Telomeres Linked to Risk of Brain Cancer
New genomic research led by UCSF scientists reveals that two common gene variants that lead to longer telomeres also significantly increase the risk of developing the deadly brain cancers known as gliomas.
Notable Progress Against Colorectal Cancer Shown in 10-Year National Study
Research led by a UCSF investigator establishes a new benchmark in the treatment of patients with metastatic colorectal cancer and sets a new expectation for how long patients can live with the particularly lethal disease.
UCSF to Present Advances in Prostate Cancer Treatment, Immunotherapy at Major Cancer Meeting
From prostate cancer to immunotherapy to genetic testing, UCSF research is providing new insights and aiding in the development of new treatment strategies for cancer.
E-Cigarettes Expose People to More Than ‘Harmless’ Water Vapor
UCSF scientists have found that industry claims about e-cigarettes are unsupported by the evidence to date, including claims that they help smokers quit.
New Cancer Immunotherapy Aims Powerful T Cells Against Tumors
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
UCSF Commentary: Cervical Cancer Expert Questions Role of HPV Testing in Screening
Screening for cervical cancer has become more complex in the last few years, leaving physicians and patients in a quandary: do they test with the traditional Pap smear or do they add a test for human papilloma virus? UCSF ob/gyn Karen Smith-McCune, MD, PhD, weighs in.
Two UCSF Professors Elected to National Academy of Sciences
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
Pancreatic Cancer 'Dream Team' Tackles Baffling, Deadly Disease
UCSF has been selected to join a national “dream team” on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.
New Breast Cancer Results Illustrate Promise and Potential of I-SPY 2 Trial
In an innovative clinical trial led by UCSF, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
Experts Question Routine Mammograms in Elderly
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
Mechanical Forces Driving Breast Cancer Lead to Key Molecular Discovery
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
Paradox of Cigarette Sales in Pharmacies Focus of New Movement
CVS Caremark, the nation’s largest pharmacy health care company, and UCSF's Steven Schroeder say selling tobacco products is “clearly antithetical” to the role of pharmacies.
